Resmed Inc
SWB:RME
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Resmed Inc
SWB:RME
|
US |
|
LVMH Moet Hennessy Louis Vuitton SE
MIL:1MC
|
FR |
|
F
|
Ferrari NV
XETRA:2FE
|
IT |
|
MSCI Inc
LSE:0A8Y
|
US |
|
Gladstone Land Corp
NASDAQ:LAND
|
US |
|
E
|
Entra ASA
OSE:ENTRA
|
NO |
|
D
|
DS Smith PLC
OTC:DITHF
|
UK |
Wall St Price Targets
RME Price Targets Summary
Resmed Inc
According to Wall Street analysts, the average 1-year price target for RME is 256.89 EUR with a low forecast of 197.28 EUR and a high forecast of 307.64 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RME's stock price target?
Price Target
256.89
EUR
According to Wall Street analysts, the average 1-year price target for RME is 256.89 EUR with a low forecast of 197.28 EUR and a high forecast of 307.64 EUR.
What is the Revenue forecast for Resmed Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is 9%.
What is the Operating Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is 11%.
What is the Net Income forecast for Resmed Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 5 years is 11%.
